The Evolving Role of Anti-VEGF Therapy in Proliferative Diabetic Retinopathy: Evidence, Challenges, and Future Directions
Clinical Ophthalmology · 2026-07 · Volume 20 · 1-10
DOI: 10.2147/opth.s620330 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Ophthalmology, 2026-07. Verfasst von Jing Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shanxi Eye Hospital Affiliated to Shanxi Medical University, Taiyuan, 030002, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Shanxi Eye Hospital Affiliated to Shanxi Medical University, Taiyuan, 030002, People's Republic of China.
- Department of Ophthalmology, The First Clinical College of Shanxi Medical University, Taiyuan, 030001, People's Republic of China.
ORCID-Profile: Guohong Zhou
Zitieren
APA
Li, J., Wang, Y., Wang, W., Zhang, X., Cui, T., & Zhou, G. (2026). The Evolving Role of Anti-VEGF Therapy in Proliferative Diabetic Retinopathy: Evidence, Challenges, and Future Directions. Clinical Ophthalmology, Volume 20, 1-10. https://doi.org/10.2147/opth.s620330
Vancouver
Li J, Wang Y, Wang W, Zhang X, Cui T, Zhou G. The Evolving Role of Anti-VEGF Therapy in Proliferative Diabetic Retinopathy: Evidence, Challenges, and Future Directions. Clinical Ophthalmology. 2026;Volume 20:1-10. doi:10.2147/opth.s620330
BibTeX
@article{Li2026,
author = {Li, Jing and Wang, Yongrui and Wang, Wenjuan and Zhang, Xiaodan and Cui, Tong and Zhou, Guohong},
title = {The Evolving Role of Anti-VEGF Therapy in Proliferative Diabetic Retinopathy: Evidence, Challenges, and Future Directions},
journal = {Clinical Ophthalmology},
year = {2026},
volume = {Volume 20},
pages = {1--10},
doi = {10.2147/opth.s620330}
}
EUVIMED